Raloxifene Hydrochloride
24 NDCs across 11 manufacturers|23 Generic,1 Brand
Raloxifene Hydrochloride is used to treat postmenopausal osteoporosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 9, 1997, and the first generic was approved Mar 4, 2014. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient.
Raloxifene Hydrochloride is available as 24 NDCs from 11 manufacturers (23 generic, 1 brand), with NADAC prices from $0.22 to $6.34 per EA — the most expensive product costs about 28× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
24
23G / 1B
Manufacturers
11
competing in market
Price Spread
$0.22 – $6.34
per EA
7d Activity
avg -5.0% WoW · of 24 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amneal Pharmaceuticals LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Estrogen Agonist/Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
11 manufacturers producing RALOXIFENE HYDROCHLORIDE(1 pricing outlier)
Frequently Asked Questions
What is Raloxifene Hydrochloride used to treat?
Raloxifene Hydrochloride is used to treat postmenopausal osteoporosis, per the National Library of Medicine's MED-RT classification.
When did Raloxifene Hydrochloride become available as a generic?
FDA approved the first generic Raloxifene Hydrochloride (ANDA) on Mar 4, 2014. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Raloxifene Hydrochloride products are on the market?
The Raloxifene Hydrochloride drug market contains 24 NDCs from 11 manufacturers — 23 generic and 1 brand product.
What is the price range for Raloxifene Hydrochloride?
NADAC reference prices for Raloxifene Hydrochloride range from $0.2235 to $6.3431 per EA — the most expensive product costs about 28× the cheapest.
Is generic Raloxifene Hydrochloride cheaper than brand?
The average generic NADAC for Raloxifene Hydrochloride is $0.2735 per EA, versus $6.3431 for brand-labeled products — brand versions average about 23× the generic price.
Which manufacturers make Raloxifene Hydrochloride?
11 manufacturers list Raloxifene Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals LLC (4), NorthStar Rx LLC (3), Dr. Reddy's Laboratories Inc. (3), Modavar Pharmaceuticals LLC (3), Glenmark Pharmaceuticals Inc., USA (2).
How has the price of Raloxifene Hydrochloride changed recently?
Over the past 7 days, 1 Raloxifene Hydrochloride NDC rose and 19 fell, with a market-wide average change of -5.0%.